Why Has The ASP of Intuitive Surgical’s da Vinci Surgical Systems Not Increased In The Last 3 Years?

-11.01%
Downside
399
Market
355
Trefis
ISRG: Intuitive Surgical logo
ISRG
Intuitive Surgical

Intuitive Surgical  (NYSE:ISRG) has seen increased orders for da Vinci  Xi Systems since its launch in 2014. However, unlike other medical device companies that provide advanced products at the cost of a higher price for the device, Intuitive has maintained the same average selling price(ASP) of $1.5 million for the da Vinci surgical systems in the last three years. Clearly, the company’s strategy is to boost volume sales and gain a significant chunk of the nascent surgical robot market before other competitors enter the field. Moreover, da Vinci surgical systems have already been in the news for its cost-efficacy concerns, so a price rise might hamper the company’s overall sales growth.

ISRG_Q&A_daVinci Systems_proportion.0

1) If you like or have any questions about our analysis, please write us back at content@trefis.com. We hope such lean communication sparks thinking, and encourages you to ask questions. The purpose of these analyses is to help you focus only on a few important things. 
2) Figures mentioned are approximate values to help our readers remember the key concepts more intuitively. For precise figures, please refer to our complete analysis for Intutitive Surgical

See More at Trefis | View Interactive Institutional Research (Powered by Trefis)

Relevant Articles
  1. Should You Pick Intuitive Surgical Stock At $375 After An Upbeat Q4?
  2. Is Intuitive Surgical Stock A Pick After A 9% Fall In A Month Amid Mixed Q3?
  3. Procedure Volume Growth To Drive Intuitive Surgical’s Q3
  4. With 2x Potential Returns Is DexCom A Better Pick Over Intuitive Surgical?
  5. Here’s What To Expect From Intuitive Surgical’s Q2
  6. Should You Buy Intuitive Surgical Stock Over MDT?

Get Trefis Technology